Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for Intrapulmonary Percussive Ventilator (IPV) devices, effective May 15, 2026. Here's what billing teams need to do.
CMS intrapulmonary percussive ventilator coverage policy changes affect durable medical equipment suppliers and respiratory therapy billing teams who submit IPV claims to Medicare. The policy does not list specific CPT or HCPCS codes in the available documentation — more on what that means for your billing process below. If your practice or DME operation bills for airway clearance devices, audit your claims workflow before May 15, 2026.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Intrapulmonary Percussive Ventilator (IPV) |
| Policy Code | N/A |
| Change Type | Modified |
| Effective Date | May 15, 2026 |
| Impact Level | Medium-High |
| Specialties Affected | Pulmonology, Respiratory Therapy, DME Suppliers, Home Health |
| Key Action | Review your IPV billing guidelines and prior authorization workflows before May 15, 2026 |
CMS Intrapulmonary Percussive Ventilator Coverage Criteria and Medical Necessity Requirements 2026
The real issue with IPV billing under Medicare has always been medical necessity. CMS has consistently treated IPV devices as covered durable medical equipment only when specific clinical conditions are documented — and that bar hasn't gotten easier to clear over time.
IPV devices deliver high-frequency oscillations to the airway. They mobilize secretions in patients who can't clear mucus effectively on their own. The clinical populations most often associated with Medicare IPV claims include patients with cystic fibrosis, bronchiectasis, and neuromuscular diseases that impair cough strength.
For a CMS claim to hold up, your documentation must connect the patient's diagnosis directly to the functional need for an IPV device. "Patient has COPD" is not enough. You need documented evidence that conventional methods — standard chest physiotherapy, for example — were tried and failed, or are clinically contraindicated.
Whether IPV is covered under Medicare depends on whether your MAC (Medicare Administrative Contractor) has an active Local Coverage Determination for airway clearance devices in your region. Not every MAC covers IPV under the same criteria. Some have issued LCDs with explicit indications; others fall back to national policy. Check your MAC's LCD library now — don't wait until a claim comes back denied.
Prior authorization requirements for IPV under Medicare are tied to your MAC's DME policies, not a single national rule. If your MAC requires prior auth for high-cost airway clearance devices, that requirement doesn't go away because CMS modified this policy. Confirm your MAC's requirements directly and update your intake workflow before the effective date of May 15, 2026.
CMS IPV Exclusions and Non-Covered Indications
CMS has historically drawn a hard line between IPV and other airway clearance modalities — and that line matters for reimbursement. The coverage policy does not treat all airway clearance as equivalent.
Patients who don't have a documented, chronic airway clearance disorder are unlikely to qualify. Acute bronchitis, post-operative mucus clearance in otherwise healthy patients, or routine pulmonary hygiene without underlying disease — these are the kinds of indications that generate claim denials.
IPV for pediatric patients billed to Medicare is rare but not impossible. When it does come up — usually in dual-eligible patients — document the clinical justification with even more care. CMS scrutinizes high-cost DME in unusual demographic patterns.
The policy documentation available does not list explicit experimental or investigational designations for specific indications. That doesn't mean everything is covered. If an indication falls outside the medical necessity criteria your MAC has established, the claim will deny. Treat the absence of an explicit exclusion list as a reason to be more careful about documentation, not less.
Coverage Indications at a Glance
The policy does not provide an itemized indication-level coverage table in the available documentation. The table below reflects the established Medicare framework for IPV coverage based on CMS policy history and MAC LCD patterns. Confirm current criteria with your MAC before May 15, 2026.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Cystic fibrosis with documented airway clearance impairment | Covered (when criteria met) | Confirm with MAC LCD | Requires documented failure of alternative methods |
| Bronchiectasis with chronic secretion retention | Covered (when criteria met) | Confirm with MAC LCD | Strong documentation of secretion burden required |
| Neuromuscular disease with impaired cough (e.g., ALS, muscular dystrophy) | Covered (when criteria met) | Confirm with MAC LCD | Physician order and functional assessment required |
| Acute bronchitis or short-term airway clearance need | Not Covered | N/A | No documented chronic condition |
| Routine pulmonary hygiene in otherwise healthy patients | Not Covered | N/A | Fails medical necessity criteria |
| Post-operative secretion clearance without underlying chronic disease | Not Covered | N/A | Acute, not chronic need |
CMS Intrapulmonary Percussive Ventilator Billing Guidelines and Action Items 2026
IPV billing generates denials for predictable, fixable reasons. Here's what to do before May 15, 2026.
| # | Action Item |
|---|---|
| 1 | Pull your MAC's current LCD for airway clearance or IPV specifically. Your MAC is the first authority on whether IPV is covered in your region and under what criteria. Don't rely on national policy alone. Go to your MAC's website, search for "intrapulmonary percussive ventilator" or "airway clearance," and download the current LCD and policy article. If your MAC recently updated its LCD, compare the new version to what your intake team is using. |
| 2 | Audit your medical necessity documentation templates. Every IPV claim needs a physician order, a diagnosis tied to a documented chronic airway condition, and evidence that less intensive methods were considered or tried. If your current templates don't capture all three of those elements, fix them before the effective date of May 15, 2026. A missing line in the intake form is the fastest path to a claim denial. |
| 3 | Confirm prior authorization requirements with your MAC before May 15, 2026. CMS modified this coverage policy, and MAC-level prior auth rules may have been updated in parallel. Call your MAC's provider services line or check their online portal. Don't assume the prior auth process you used in 2025 still applies. |
| 4 | Update your charge capture to reflect correct HCPCS coding for IPV devices. This policy does not list specific codes in the available documentation. That's a red flag — it means you need to verify the correct HCPCS code for IPV with your MAC directly. Using an incorrect or outdated code is a denial waiting to happen. Get the right code confirmed in writing from your MAC or billing consultant before submitting claims under the modified policy. |
| 5 | Review your ABN (Advance Beneficiary Notice) process for IPV. If your MAC's LCD doesn't cover a patient's specific indication, you need an ABN on file before you provide the device. This protects your organization from absorbing the cost when Medicare denies the claim. Train your intake team on the covered versus non-covered indications — the table above is a starting framework, but your MAC's LCD is the final word. |
| 6 | If your organization bills high volumes of IPV claims, loop in your compliance officer before May 15, 2026. Policy modifications from CMS on DME items often come with updated documentation requirements or coding guidance. Your compliance officer should review the updated policy language directly and confirm your billing guidelines align with the new requirements. Don't treat this as a routine update until someone on your team has read the actual policy document. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Intrapulmonary Percussive Ventilator Under This Policy
The CMS Intrapulmonary Percussive Ventilator coverage policy does not list specific CPT, HCPCS, or ICD-10 codes in the available policy documentation.
This is important for your billing team. Do not assume the codes you've been using are correct without verifying them against your MAC's current LCD and the updated CMS policy. Using an unverified code on an IPV claim creates unnecessary denial risk.
How to Find the Right Codes
Contact your MAC's provider services team and ask specifically which HCPCS codes apply to IPV devices under the updated policy effective May 15, 2026. Ask for the policy article number, not just the LCD — policy articles contain the actual billing and coding instructions that LCDs don't always include.
Your billing consultant or DME coding specialist can also cross-reference the device against the HCPCS Level II code set. IPV devices typically fall within the respiratory equipment range, but the exact code depends on device classification and your MAC's billing instructions.
ICD-10-CM Diagnosis Codes
No ICD-10-CM codes are listed in the available policy documentation. Your MAC's LCD policy article is the authoritative source for which diagnosis codes support medical necessity for IPV under Medicare. Pull that list and build it into your charge capture system.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.